XML 74 R63.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue recognition - Narrative (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Oct. 31, 2017
USD ($)
Nov. 30, 2014
USD ($)
Jan. 31, 2014
USD ($)
Aug. 31, 2013
USD ($)
Nov. 30, 2011
USD ($)
compound
Mar. 31, 2019
USD ($)
segment
deliverable
Mar. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
deliverable
Dec. 31, 2018
USD ($)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Contract with Customer, Liability           $ 14,350,000 $ 9,300,000 $ 11,891,000 $ 12,938,000
Number of operating segments | segment           1      
Net product revenue           $ 53,054,000 55,981,000    
Upfront cash payment           1,412,000 1,346,000    
Revenue           53,583,000 56,062,000    
Performance obligations satisfied in current period             55,981,000    
Licensing And Collaboration Agreement                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Upfront cash payment         $ 30,000,000        
Performance obligations satisfied in current period $ 20,000,000 $ 10,000,000 $ 7,500,000 $ 10,000,000          
Licensing And Collaboration Agreement | Research And Development Event Milestones                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Revenue recognition, milestone, potential achievements         135,000,000 87,500,000      
Licensing And Collaboration Agreement | Sales Milestones                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Revenue recognition, milestone, potential achievements         $ 325,000,000 325,000,000      
Discovery Agreements                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Revenues           0 0    
Early Stage Collaborations                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Revenues           0 0    
Early Stage Collaborations | Research And Development Event Milestones                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Revenue recognition, milestone, potential achievements           143,000,000      
Early Stage Collaborations | Sales Milestones                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Revenue recognition, milestone, potential achievements           252,000,000      
United States                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Net product revenue           17,800,000 19,200,000    
Non-US                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Net product revenue           $ 35,300,000 36,800,000    
Collaborative Arrangement | Roche And Sma Foundation                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Number of compounds in preclinical development | compound         3        
Number of significant deliverables | deliverable               2  
Collaboration And Discovery Agreements                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Number of significant deliverables | deliverable           2      
Minimum | Collaboration And Discovery Agreements                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Collaborative arrangements research period for applying discovery technology           3 years      
Maximum | Collaboration And Discovery Agreements                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Collaborative arrangements research period for applying discovery technology           4 years      
Roche | Licensing And Collaboration Agreement                  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                  
Revenues           $ 100,000 $ 100,000